Dyadic to Attend J.P. Morgan 42nd Annual Healthcare Conference
January 02, 2024 08:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...
SOLIRIS Drug Insight and Market Forecasts, 2032: Focus on 7 Major Markets - United States, Germany, France, Italy, Spain, United Kingdom, and Japan
December 07, 2023 09:43 ET
|
Research and Markets
Dublin, Dec. 07, 2023 (GLOBE NEWSWIRE) -- The "SOLIRIS Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
Global Antibody Collaboration and Licensing Agreement Analysis Report 2023 with Directory of 1,812 Deals Signed Since 2016
November 17, 2023 06:43 ET
|
Research and Markets
Dublin, Nov. 17, 2023 (GLOBE NEWSWIRE) -- The "Antibody Collaboration and Licensing Deals 2016-2023" report has been added to ResearchAndMarkets.com's offering.This report contains a comprehensive...
In Silico Drug Discovery Market Size Worth USD 11.68 Billion in 2032 | Emergen Research
November 15, 2023 12:22 ET
|
Emergen Research
Vancouver, Nov. 15, 2023 (GLOBE NEWSWIRE) -- The global In Silico Drug Discovery Market is forecasted to be worth USD 11.68 Billion by 2032, according to a current analysis by Emergen Research. The...
Dyadic Announces Third Quarter 2023 Financial Results and Highlights Recent Company Progress
November 08, 2023 16:00 ET
|
Dyadic International, Inc.
Received an upfront payment of $0.6 million in October for product development and licensing of our Dapibus™ platform for animal-free dairy enzyme productsDYAI-100 Phase 1 clinical trial top-line...
The Global Market for Bispecific Antibody Therapeutics Contract Manufacturing 2023-2030: Driven by Demand for Innovative Therapies and Promising Results Seen in Clinical Development
November 06, 2023 09:04 ET
|
Research and Markets
Dublin, Nov. 06, 2023 (GLOBE NEWSWIRE) -- The "Global Bispecific Antibody Therapeutics Contract Manufacturing Market 2023-2030" report has been added to ResearchAndMarkets.com's offering. The...
China Bispecific Antibodies Market and Clinical Pipeline Insight Report 2023-2028: Akeso are Leading the Way and Gaining Global Recognition for their Innovative Clinical Candidates
November 06, 2023 04:23 ET
|
Research and Markets
Dublin, Nov. 06, 2023 (GLOBE NEWSWIRE) -- The "China Bispecific Antibodies Market and Clinical Pipeline Insight 2028" drug pipelines has been added to ResearchAndMarkets.com's offering. The...
Monoclonal Antibodies Market to Reach US$ 364 Billion by 2028, Driven by Rising Prevalence of Chronic Diseases and Technological Advancements
November 03, 2023 07:37 ET
|
Rationalstat LLC
Wilmington, Delaware, Nov. 03, 2023 (GLOBE NEWSWIRE) -- According to RationalStat’s most recent industry analysis, the Global Monoclonal Antibodies Market value is US$ 196.6 billion in 2023 and is...
Global CD3 Antibodies Market 2023-2028: New-Generation CD3 Antibodies Targeting Diverse Indications Gain Ground
November 02, 2023 07:43 ET
|
Research and Markets
Dublin, Nov. 02, 2023 (GLOBE NEWSWIRE) -- The "Global CD3 Antibodies Market, Dosage, Price, Sales & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com's offering. ...
Dyadic to Present at Industry Events in November
October 30, 2023 08:30 ET
|
Dyadic International, Inc.
Dyadic to Present at Industry Events in November